TC Biopharm (Holdings) Plc (TCBPY)
OTCMKTS · Delayed Price · Currency is USD
0.0060
+0.0010 (20.00%)
Apr 1, 2026, 4:00 PM EST
TC Biopharm (Holdings) Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
39
Market Cap
11.57K USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 3.84M | 1.87M | 94.30% |
| Dec 31, 2021 | 1.98M | - | - |
| Dec 31, 2020 | 1.98M | -1.45M | -42.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aridis Pharmaceuticals | 22.36M |
| ObsEva | 19.64M |
| Statera Biopharma | 3.69M |
| GeneLink | 1.58M |
| Trevena | 546.00K |
| America Great Health | 382.86K |
| Therapeutic Solutions International | 85.32K |
| Health Sciences Group | 69.31K |
TC Biopharm (Holdings) News
- 10 months ago - TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient - PRNewsWire
- 1 year ago - TCBP Announces Grant of European Patent for Targeting of Microbial, Oncological, and Viral Indications using Modified Gamma Delta T Cells - PRNewsWire
- 1 year ago - TCBP Announces Transition from Nasdaq to OTC Markets - PRNewsWire
- 1 year ago - TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead - PRNewsWire
- 1 year ago - TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company - PRNewsWire
- 1 year ago - TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum - PRNewsWire
- 1 year ago - TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial - PRNewsWire
- 1 year ago - TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial - PRNewsWire